Measuring a grey area in medication deployment reveals delays from invention to clinical use of rheumatoid arthritis medications
- PMID: 35965815
- PMCID: PMC9372696
- DOI: 10.21037/atm-22-3234
Measuring a grey area in medication deployment reveals delays from invention to clinical use of rheumatoid arthritis medications
Conflict of interest statement
Conflicts of Interest: The author has completed the ICMJE uniform disclosure form (available at https://atm.amegroups.com/article/view/10.21037/atm-22-3234/coif). The author has no conflicts of interest to declare.
Comment on
-
How long does it take to translate research findings into routine healthcare practice?-the case of biological drugs for rheumatoid arthritis in Brazil.Ann Transl Med. 2022 Jul;10(13):738. doi: 10.21037/atm-22-397. Ann Transl Med. 2022. PMID: 35957709 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources